Annual report pursuant to Section 13 and 15(d)

Business and Organization (Details)

v3.3.1.900
Business and Organization (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Aug. 31, 2015
USD ($)
$ / shares
shares
May. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2015
person
Bio-Reference Laboratories, Inc.      
Business Acquisition [Line Items]      
Common stock value $ 2,259    
Total purchase price $ 950,148    
EirGen Pharma Limited      
Business Acquisition [Line Items]      
Common stock value   $ 33,600  
Total purchase price   133,800  
Total purchase price   $ 100,200  
Common Stock      
Business Acquisition [Line Items]      
Stock price | $ / shares $ 12.38 $ 13.88  
Common Stock | Bio-Reference Laboratories, Inc.      
Business Acquisition [Line Items]      
Common stock received, in shares | shares 76,566,147    
Acquired entity share price | $ / shares $ 34.05    
Common Stock | EirGen Pharma Limited      
Business Acquisition [Line Items]      
Common stock received, in shares | shares   2,420,487  
Diagnostics      
Business Acquisition [Line Items]      
Sales force, persons | person     420